In the evolving landscape of pharmaceutical development, mass spectrometry (MS) has become a cornerstone of analytical strategy. As regulatory expectations rise and product complexity increases, the ability to accurately detect, characterize, and quantify impurities and molecular structures is more critical than ever. MS provides the sensitivity, specificity, and adaptability required to support everything from early-stage development to commercial product release.
At SK pharmteco, our analytical testing services include advanced mass spec capabilities designed to support small molecules, biologics, and advanced therapies. Our MS platforms play a central role in method development, structural elucidation, and impurity profiling across a wide range of therapeutic modalities.
Why Mass Spectrometry Matters
Mass spectrometry enables precise identification of chemical entities at extremely low concentrations, which is essential for ensuring product safety and meeting global regulatory standards. Whether confirming API identity, detecting trace-level impurities, or verifying molecular weight, MS is indispensable to CMC analytical development and product lifecycle management.
In small-molecule programs, MS is used to characterize degradation products and validate synthesis pathways. For biologics and peptides, it supports higher-order structure analysis, glycosylation profiling, and post-translational modification assessment—areas where conventional analytical tools may fall short.
Applications in Impurity Profiling and Regulatory Filings
Impurity profiling is a critical application of MS, particularly under ICH Q3A/B guidelines, which require detailed documentation of related substances, residual solvents, and degradation products. SK pharmteco integrates MS into its analytical method validation workflows to support IND, NDA, and BLA filings. Our experienced scientists develop robust, reproducible assays using LC-MS, GC-MS, and high-resolution MS platforms, ensuring data integrity and regulatory confidence.
Supporting Gene Therapy Programs
In advanced modalities such as gene therapies, MS services provide critical insight into components like plasmid purity, residual host cell proteins, and viral capsid characterization. These analyses support product comparability, identity testing, and release specifications. At SK pharmteco, MS is integrated into our comprehensive analytical services for CGT programs, enabling clients to meet the rigorous demands of emerging regulatory pathways.
Mass Spectrometry Within a Broader Analytical Framework
At SK pharmteco, MS is not viewed in isolation – it is a vital part of our integrated analytical offering. MS data informs process development, guides scale-up decisions, and supports long-term stability studies. When combined with chromatographic, spectroscopic, and bioassay data, MS enables a 360-degree view of product quality and risk mitigation.
Work with SK pharmteco for Advanced Mass Spectrometry Services
As part of our specialized analytical development offerings, SK pharmteco delivers high-quality, compliant MS services tailored to your program’s stage and modality. From impurity profiling to molecular characterization, our expert team brings clarity, speed, and confidence to every step of your product development process.
Contact us to learn how our mass spectrometry capabilities can support your analytical goals and regulatory submissions.